Biomarker-driven approaches appear critical, as SCLC studies identify T-cell-inflamed microenvironments (dual PD-L1+/CD8+ T-cell infiltration) as predictors of ICI responsiveness (18). This evidence concerns the gene CD274 and small cell lung carcinoma.